Vincent Medical Holdings Limited (1612.HK)
HKD 0.39
(-2.5%)
HKD 0.39
(-2.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 125.67 Million | 76.27 Million | 119.43 Million | 204.77 Million | 31.31 Million | 35.07 Million |
| Net Income | 57.27 Million | -17.39 Million | 60.69 Million | 216.86 Million | 11.52 Million | 30.94 Million |
| Depreciation & Amortization | 38.65 Million | 40.95 Million | 40.06 Million | 37.01 Million | 28.55 Million | 14.69 Million |
| Deferred income taxes | -82.88 Million | -85.56 Million | -102.35 Million | -255.36 Million | -80.85 Million | 5.6 Million |
| Stock-based compensation | 1.87 Million | 2.93 Million | 1.07 Million | 928 Thousand | 2.1 Million | 2.71 Million |
| Change in working capital | 20.34 Million | 7.48 Million | -18.84 Million | -139.88 Million | -31.93 Million | -8.32 Million |
| Other non-cash items | 90.4 Million | 127.86 Million | 138.8 Million | 345.2 Million | 101.92 Million | -10.56 Million |
| Investing Cash Flow | -63.06 Million | -18.6 Million | -20.69 Million | -132.19 Million | -32.7 Million | -61.26 Million |
| Investments in PPE | -63.69 Million | -18.59 Million | -24.95 Million | -62.57 Million | -33.89 Million | -21.36 Million |
| Acquisitions | 637 Thousand | -10 Thousand | 12.01 Million | -69.61 Million | 1.19 Million | 50 Thousand |
| Investment purchases | -5000.00 | -10 Thousand | -7.75 Million | - | - | -32.22 Million |
| Sales/Maturities of investments | 30.73 Million | -490 Thousand | -4.43 Million | - | - | 32.17 Million |
| Other Investing Activities | -30.73 Million | 500 Thousand | 4.43 Million | -10.14 Million | -2.69 Million | -39.9 Million |
| Financing Cash Flow | -45.36 Million | -67.83 Million | -101.16 Million | 10.12 Million | -6.6 Million | -532 Thousand |
| Debt repayment | -17.43 Million | -16.1 Million | -3.97 Million | -36.26 Million | -13.41 Million | -2.19 Million |
| Dividends payments | -8.04 Million | -32.68 Million | -85.24 Million | -7.01 Million | -10.2 Million | -9.56 Million |
| Common Stock Repurchased | -3.27 Million | -2.64 Million | -1.62 Million | -13.48 Million | - | -228 Thousand |
| Common Stock Issuance | - | 211 Thousand | 4.65 Million | 10.35 Million | - | 2.42 Million |
| Other Financing Activities | -80 Thousand | -16.6 Million | -14.97 Million | 56.53 Million | 17 Million | 9.03 Million |
| Accounts receivables | -13 Million | 8 Million | -6.37 Million | -56.09 Million | 1.33 Million | 5.87 Million |
| Accounts payables | 17.34 Million | -22.77 Million | -21.09 Million | 45.28 Million | 2.46 Million | -2.46 Million |
| Inventory | -8.03 Million | 14.04 Million | 6.31 Million | -169.59 Million | -25.44 Million | -14.19 Million |
| Other working capital | 24.04 Million | 8.21 Million | 2.31 Million | 40.51 Million | -10.29 Million | 2.46 Million |
| Cash at beginning of period | 159.34 Million | 173.16 Million | 169.06 Million | 69.95 Million | 81.14 Million | 112.99 Million |
| Cash at end of period | 175.78 Million | 159.34 Million | 173.16 Million | 169.06 Million | 69.95 Million | 81.14 Million |
| Capital Expenditure | -63.69 Million | -18.59 Million | -24.95 Million | -62.57 Million | -33.89 Million | -21.36 Million |
| Effect of forex changes on cash | -799 Thousand | -3.65 Million | 6.51 Million | 16.46 Million | -3.2 Million | -5.13 Million |
| Net cash flow / Change in cash | 16.44 Million | -13.82 Million | 4.09 Million | 99.11 Million | -11.19 Million | -31.85 Million |
| Free Cash Flow | 61.97 Million | 57.67 Million | 94.47 Million | 142.19 Million | -2.57 Million | 13.71 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 33.28 Million | 30.67 Million | 57.27 Million | 26.6 Million | -17.39 Million | 26.96 Million |
| Depreciation & Amortization | 17.77 Million | 18.8 Million | 38.65 Million | 19.84 Million | 40.95 Million | 19.89 Million |
| Deferred income taxes | - | -41.31 Million | -82.88 Million | - | -85.56 Million | -63.47 Million |
| Stock-based compensation | 609 Thousand | 700 Thousand | 1.87 Million | 1.17 Million | 2.93 Million | 1.63 Million |
| Change in working capital | - | 3 Million | 20.34 Million | - | 7.48 Million | 30.26 Million |
| Other non-cash items | -18.29 Million | 78.91 Million | 90.4 Million | 28.13 Million | 127.86 Million | 42.8 Million |
| Investing Cash Flow | -22.29 Million | -52.11 Million | -63.06 Million | -10.95 Million | -18.6 Million | -14.13 Million |
| Investments in PPE | -20.26 Million | -52.4 Million | -63.69 Million | -11.29 Million | -18.59 Million | -13.97 Million |
| Acquisitions | 1.34 Million | 637 Thousand | 637 Thousand | - | -10 Thousand | - |
| Investment purchases | - | -5000.00 | -5000.00 | - | -10 Thousand | -10 Thousand |
| Sales/Maturities of investments | - | 1.00 | 30.73 Million | - | -490 Thousand | - |
| Other Investing Activities | -2.03 Million | -341 Thousand | -30.73 Million | 341 Thousand | 500 Thousand | -144 Thousand |
| Financing Cash Flow | -17.69 Million | -7.4 Million | -45.36 Million | -37.96 Million | -67.83 Million | -38.35 Million |
| Debt repayment | -7.18 Million | -8.8 Million | -17.43 Million | -26.23 Million | -16.1 Million | -12.8 Million |
| Dividends payments | -9.65 Million | -8.04 Million | -8.04 Million | - | -32.68 Million | -16.33 Million |
| Common Stock Repurchased | - | - | -3.27 Million | -3.27 Million | -2.64 Million | -1.08 Million |
| Common Stock Issuance | - | - | - | - | 211 Thousand | 13.87 Million |
| Other Financing Activities | -861 Thousand | 635 Thousand | -80 Thousand | -80 Thousand | -16.6 Million | -20.93 Million |
| Accounts receivables | - | -13 Million | -13 Million | - | 8 Million | 8 Million |
| Accounts payables | - | - | 17.34 Million | - | -22.77 Million | - |
| Inventory | - | -8.03 Million | -8.03 Million | - | 14.04 Million | 14.04 Million |
| Other working capital | - | 24.04 Million | 24.04 Million | - | 8.21 Million | 8.21 Million |
| Cash at beginning of period | 175.78 Million | 141.81 Million | 159.34 Million | 159.34 Million | 173.16 Million | 163.99 Million |
| Cash at end of period | 166.73 Million | 175.78 Million | 175.78 Million | 141.81 Million | 159.34 Million | 159.34 Million |
| Capital Expenditure | -20.26 Million | -52.4 Million | -63.69 Million | -11.29 Million | -18.59 Million | -13.97 Million |
| Effect of forex changes on cash | -2.44 Million | 2.7 Million | -799 Thousand | -3.5 Million | -3.65 Million | -2.04 Million |
| Net cash flow / Change in cash | -9.05 Million | 33.96 Million | 16.44 Million | -17.52 Million | -13.82 Million | -4.65 Million |
| Free Cash Flow | 13.11 Million | 38.38 Million | 61.97 Million | 23.59 Million | 57.67 Million | 35.9 Million |
ENDI
7712
AVER
INTUCH
5604
FLGC